Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPB-SYSHEART
NCT07259057Completed
- Sponsor
- Karadeniz Technical University
- Start
- Jan 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Karadeniz Technical University. Primary endpoint: Postoperative Pain Intensity at 12 hours. Started Jan 2023; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07259057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07259057.